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Abstract 
Introducing hydrophilic functions on poly(vinylidene fluoride) (PVDF) films surface allows the covalent 
immobilization of peptides. Therefore radiation grafting of acrylic acid (AA) in pre-irradiated PVDF films was 
achieved to allow surface functionalization with linear and cyclic peptides. Peptides were bound via spacer 
molecules using EDC as a coupling agent. The reactions were followed by Fourier Transform Infrared (FTIR) 
spectroscopy in attenuated total reflection (ATR) mode. The amount of immobilized peptides was determined by 
UV spectroscopy. As well, an uncommon method for PVDF characterization and reactions quantification was 
used: HR-MAS NMR. Spacer saturation of the film surface corresponded to 25 mol % yield meaning that one 
spacer on 4 carboxylic acids was covalently bound. XPS experiments were also performed to deepen analysis of 
the surface composition. Peptide density is governed by steric hindrance. ELISA tests showed that the peptides' 
activity is maintained. 
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1. Introduction 
 
Angiogenesis constitutes a physiological response to ischemia [1,2]. Neovascularization of 
ischemic cardiac or skeleton muscle may be sufficient to preserve tissue integrity and may 
thus be considered to be therapeutic. The biological activity may be brought by small peptides 
miming the vascular endothelial growth factor (VEGF) effect on angiogenesis response [3]. 
Immobilizing such peptides onto a solid polymeric support is of great interest for biomedical 
applications. 
 In the present work, we have chosen poly(vinylidene fluoride) (PVDF) as polymeric support. 
It is a fluorinated thermoplastic polymer which is biocompatible and can be processed in 
various forms. Ionizing radiation on PVDF allows hydrophobic PVDF films to endow 
hydrophilic properties by grafting acrylic acid (AA). In a previous study [4], we have shown 
that, under certain conditions, PAA totally covers the PVDF surface. All PAA carboxylic 
acids become consequently as many anchoring sites to immobilize peptides. In order to bring 
mobility to the peptides, spacer molecules have to be introduced. In addition, these may be 
designed to undergo enzymatic cleavage depending on the application requirements. This 
paper reports on subsequent coupling reactions which have been carried out and followed by 
FTIR, HR-MAS NMR and XPS. Chemistry synthesis details are discussed and immobilized 
peptide activity has been also investigated. 
 
2. Experimental Section 
 
2.1. Materials and Reagents.  
 
Hydrophobic 25 µm thick  PVDF films (Atochem) were Soxhlet-extracted in toluene and 
dried at 50 °C under vacuum before use. The following chemicals and bio-chemicals were 
purchased from Sigma-Aldrich and used as received : acrylic acid (AA), Mohr’s salt 
[FeH8N2O8S2.6H2O], ethyl-3-(3-dimethylaminopropyl)carbodiimide C8H17N3.HCl (EDC), 
trifluoroacetic acid (TFA), sulphuric acid H2SO4, N-hydroxysuccinimide (NHS), acetate 
buffer (pH 5), 3,3’,5,5’-tetramethylbenzidine (TMB), bovine serum albumin (BSA), 0.05 % 
Tween-20 in phosphate buffered solution (PBS-Tween), primary antibody DB4, peroxydase-
conjugated anti-mouse IgG (secondary antibody). Peptides were synthesized by INSERM 
U577’s team (Bordeaux, France) : P(242-261) H-Ser-Pro-Asn-Val-Ser-Val-Pro-Ser-Ser-Ser-
Ser-Thr-Pro-Leu-Leu-Tyr-Pro-Ser-Leu-Ala-OH (2 003.2 g/mol), P(253-261) (1 031 g/mol), 
P(236-245) HO-Thr-Trp-His-Val-Leu-Tyr-Ser-Pro-Asn-Val-H (1 213 g/mol), P(237-245) (1 
114.2 g/mol) and P11, a cyclic peptide of 17 aminoacids (2 000 g/mol) [3]. The spacer used, 
noted TEG, is a functionalized triethyleneglycol with an amine function at one end and a 
tertio-butyl protected carboxyl acid at the other end. It was synthesized at the INSERM. Ion-
exchange water was used needed. 
 
2.2. Immobilization of peptides via a spacer on poly(acrylic acid)-radiation-grafted PVDF 
[Scheme 1]. 
 
Films were irradiated at RT under helium at 150 kGy (dose-rate : 500 kGy/h) using a 2.5 
MeV Van de Graaf accelerator. Immediately after irradiation films were stored under nitrogen 
atmosphere at RT. Grafting (1 h, 60 °C) is performed in a pure AA solution with 25 wt % 
concentration of Mohr’s salt using the procedure described in [5]. PVDF-g-PAA films with a 
grafting yield of 10 wt % (ca. 16 µmol of AA) were first coupled to TEG in EDC aqueous 
solution (160 µmol in 50 ml, [TEG]/[EDC]=1). Reaction ran 4 h at RT and gave 25 mol % 
yields. The films were immersed in TFA / H2O (95 v %) for 1 h at 70 °C. Films were 
activated in 1.76 mM EDC and 1.78 mM NHS for 4 h at RT. Films were washed in water and 
equilibrated with 0.7 M acetate buffer (pH 5). The NHS activated films were immersed for 48 
h in 0.7 M acetate buffer containing peptides (0.339 mg/ml). 
 
2.3. Spectroscopic characterization.  
 
FTIR spectra of the polymer films were carried out with a Nicolet Magna-IR
TM
 750 
spectrometer equipped with a DTGS detector. Spectra were recorded in Attenuated Total 
Reflection mode (ATR) using a diamond-crystal with single reflection cumulating 32 scans at 
a resolution of 2 cm
-1
. 
Quantitative determination of linear and cyclic peptides in acetate buffer was performed using 
a UV-visible spectrometer UNICAM UV 300. Calibration curves were obtained at 280 nm 
and 220 nm corresponding to the specific maximum of linear and cyclic peptide UV 
absorption respectively. 
HR-MAS NMR spectroscopy experiments were performed using an Avance 500 spectrometer 
equipped with an HR-MAS dual probe (
1
H/
13
C)  and 4 mm HR-MAS Rotor (ZrO2) –no insert-
. Deuterated DMF, solvent of both PVDF and PAA, was used.  
X-ray photoelectron (XPS) spectra were recorded on a HP5950A spectrometer using a 
monochromatic Al K X-ray source. A flood gun was used to cancel charging-up effects. The 
resolution was 0.8-1 eV. Binding energies were determined by reference to the C1S 
component due to carbon bond set at 285 eV. Linear baseline for background subtraction and 
Gaussian functions were used for peak fitting. Atomic percentages were determined from 
peak areas by using Scofield factors [6]. 
 
2.4. ELISA test 
 
An antigenic peptide and a control peptide corresponding respectively to the 
sequences 242-261 and 237-245 of the Gp46 protein from the Human T-cell Lymphotropic 
Virus (HTLV-1) were synthesized and immobilized on PVDF-g-PAA (section 2.2). Films 
were placed into wells of a 12-well plates. The plates were covered and incubated in a 
blocking solution (3 % BSA in PBS-Tween) under stirring at 37 °C for 1.5 h. After washing 
in PBS-Tween, 500 µL of diluted primary antibody DB4 (1/80000 in 1% BSA in PBS-
Tween) were added to selected wells. After covering, samples were incubated at 4 °C for 18 h 
under stirring and washed. Then, diluted secondary antibody solution (1/10000 in 1% BSA in 
PBS-Tween) was added, plates were covered, incubated under stirring at 37 °C for 1 h and 
washed. TMB (500 µL/well) was added, plates were covered and incubated at room 
temperature for 15 min under stirring. Reactions were stopped by 0.5M H2SO4. Tests were 
run in triplicate. Reaction supernatants were transferred to a 96-well plate and absorbance was 
read at 450 nm in a MRX microplate reader (Dynex technologies). Two ELISA controls (one 
without primary antibody and another without solid support) were run to ensure that the 
colorimetric reaction was due to the molecular recognition and not to a non-specific reaction. 
 
3. Results and Discussion 
 
3.1. FTIR characterization and UV backtitration 
 
Under our experimental conditions, surface grafting was favored [4,5]. The chemical 
functions of PVDF-g-PAA (1) copolymer films are identified by FTIR (Figure 1) and were 
specified in detail in a previous work [5]. Scheme 1 illustrates all chemical steps from PVDF-
g-PAA (1) copolymers to PVDF-g-PAA-TEG-Peptide (5) films. A first step consists in 
attaching the TEG spacer onto grafted films to bring mobility to the future immobilized 
peptide. Covalent linkage of TEG is achieved through chemical coupling of its amino groups 
to the PAA carboxyl groups using a water-soluble carbodiimide (EDC). Figure 2 displays 
specific IR peaks of amide bond formation at 1644 cm
-1
 and 1547 cm
-1
 as well as the 
characteristic TEG absorptions (t-butyl, CH2, ester and ether vibrations at 2980 cm
-1
, 
2860/2870 cm
-1
, 1726 cm
-1
 and 1100 cm
-1
, respectively). After t-butyl cleavage step (scheme 
1), a second coupling reaction is performed to attach the peptide by coupling its amino groups 
to the TEG carboxylic acid groups using EDC and NHS. PVDF-g-PAA-TEG (3) acid groups 
are activated with NHS which leads to the intermediate PVDF-g-PAA-TEG-NHS (4). 
Primary amine groups are well known to react specifically with NHS activated carboxyl 
acids. By this way, there is no need to protect the terminal carboxylic acid of the peptide to 
avoid peptide homopolymerization. Three peptides have been used : two linear ones, P(253-
261) and P(236-245), and a cyclic one, noted P11 [3]. The last one specifically mimes the 
VEGF effect on angiogenesis [7]. In Figure 3, the ester vibration corresponding to NHS 
activated carboxyl acid group is clearly observed at 1732 cm
-1
 as well as the succinic ester N-
O vibration at 1205 cm
-1
. Immobilization of peptides induces a significant decrease of these 
peaks which indicates that most of NHS sites on the surface have reacted. The residual 
absorptions are due to a lack of accessibility of NHS activated acids to peptide molecules due 
to steric hindrance in relation to heterogeneous phase reaction.  
The amounts of covalently immobilized peptides are evaluated by performing UV spectra of 
supernatant peptide solution. The resulting yield is found equal to 12 mol % in TEG 
equivalent (similar to 10 ± 2.2 mol % found gravimetrically) for linear peptides and 7.38 mol 
% for cyclic ones. This is a high binding density value, even if it is finally equal to only 0.24 
mol % of initial PVDF repeat units. 1 linear peptide molecule is then immobilized for 10 TEG 
molecules and 1 cyclic peptide molecule for 15 TEG molecules. Indeed, binding densities are 
governed by their individual three-dimensional space requirements.  
 
3.2. 
1
H and 
13
C HR-MAS NMR characterization 
 
Irradiation is performed at an absorbed dose higher than the gel dose. Therefore PVDF is 
crosslinked and films are not fully soluble in DMF anymore. Solid state spectra, in such a 
case, generally display a poor resolution. A solution to this dilemma is to swell the films with 
the DMF and to acquire spectra while spinning at magic angle. Figure 4 shows a proton-
carbon correlation spectrum of a highly grafted PVDF film swollen in DMF-d7. 
1
H spectrum 
displays large peaks at 1.979 ppm and 1.722 ppm corresponding to the CH2 of PAA. One 
would expect only one signal at 1.722 ppm. The chemical shift observed for 33 % of the PAA 
CH2 at 1.979 ppm may be attributed to CH2 bound directly on a CF/CF2 of PVDF or on a 
peroxide. At 2.502 ppm, a large peak is seen which is due to the superimposition of the CH of 
PAA and a triplet corresponding to the CH3 of PVDF chain ends. These chain ends (around 
10 mol % of PVDF) are assumed to come from PVDF chain scissions during radiation 
process. The large multiplet at 3.038 ppm is the CH2 of PVDF repeat unit signal. Carbon 
peaks of PVDF are detected at 23 ppm for chain ends, a triplet at 43 ppm for CH2 and a well-
resolved triplet at 120 ppm for CF2. From integrated signals, a quantitative approach allows us 
to evaluate accurately the AA/PVDF ratio. For example, a PAA yield of 7.23 mol % is 
calculated from HR-MAS NMR spectrum of a 10 w % grafted PVDF while 6 mol % are 
obtained from gravimetric measurements. The spectra of 5 presented in Figure 5 evidences 
the covalent linkage of the peptide by the presence of well-defined aromatic 
1
H peaks. The 
yield of immobilized peptide is calculated from the HR-MAS NMR spectrum as 2(Iarom/11)/( 
IPVDF-6IDMF), where Iarom is the peak area of the signal of the 11 aromatic peptide protons, 
IPVDF  is the peak area of the CH2 PVDF signal (two protons) and IDMF is the peak area of CH 
DMF at 8.2 ppm. Calculation gives 0.18 mol % of PVDF repeat units for one immobilized 
peptide. In comparison, the UV titration gave a peptide/PVDF ratio of 0.24 mol % while 0.19 
mol % is obtained gravimetrically. 
 
3.3. XPS characterization 
 
Table 1 summarizes atomic ratios obtained from XPS survey spectra (not shown) while 
Figure 6 presents the C1s lines. Virgin PVDF exhibits in addition to the expected C and F 
content, little oxidation (3.2 %) due to film storage. After grafting, a huge increase of oxygen 
percentage is observed due to PAA carboxylic acids. F signal decreases to less than 1%. There 
is a significant increase in the N content going from TEG to peptide coupling reactions. 
Further information on PVDF surface modification is obtained from the C1s spectra. Virgin 
PVDF C1s spectrum displays two peaks at 286.6 and 291.1 eV for CH2 and CF2, respectively. 
After grafting, PVDF peaks are no longer visible and three carbon peaks corresponding to 
PAA groups are observed at 284.8 eV, 285.2 eV and 289 eV for CH2, CH and COOH 
respectively [8]. This means that the grafted PAA is located on the surface with 100% of 
coverage [4]. C1s spectrum of 2 displays a high ether peak at 286.6 eV specific of TEG 
presence. The amide peak, present in C1s spectrum of 2, dramatically increases at 288.4 eV on 
C1s core level spectrum of 5. C1s features of 5 assignment is in agreement with other studies 
on peptide characterization [9,10]. A * characteristic shake-up of aromatic carbons hold by 
P(236-245) is also detected at 291 eV. O/C, N/C and N/O ratios of 5 correspond to the 
calculated value of a peptide molecule for 10 TEG molecules. This confirms the UV results. 
Consequently, it is concluded that the peptide is mainly located on the surface of 
functionalized grafted PVDF films. 
 3.4. ELISA test 
 
In order to evaluate peptide's activity after immobilization, ELISA tests were 
performed to determine if molecular recognition is still possible after grafting of the antigenic 
peptide on the functionalized solid support. Results (Figure 7) are evaluated by comparing : i) 
the O.Ds of each samples to their respective control (i.e without antibody DB4) to evaluate 
non-specific reaction of the secondary antibody, ii) the O.Ds resulting from the samples with 
antigen and iii) the O.Ds resulting from the samples with control peptide to determine non-
specific reaction of the antibody DB4. Non-specific reaction with BSA from blocking solution 
was evaluated for measurement correction. O.D variation obtained for PVDF-g-PAA-TEG-
antigen compared to all the other films and control experiments is sufficiently significant to 
conclude that antigen-antibody specificity is maintained.  
 
4. Conclusion 
 
In investigated conditions, electron beam irradiation permits us to obtain PAA covalently 
grafted onto the PVDF film surface. We have shown that the immobilization of peptides onto 
PVDF-g-PAA films surface via a spacer can be easily obtained by coupling reactions in mild 
conditions. All chemical functionalizations take place mainly on the films surface and yields 
are governed by steric hindrance considerations. Immobilized peptides are located in the first 
nanometers of films surface. Among several spectroscopic techniques, HR-MAS NMR 
appears to be the most accurate technique to detect low peptide quantities. In addition, HR-
MAS NMR may also give us information about secondary structure of peptide bound to solid 
supports [11]. It would be then interesting to exploit this property to compare with biological 
data. Indeed, PVDF-g-PAA-TEG-peptide copolymer films offer a great biomedical interest. 
By varying peptide sequences and spacer, it may be possible to develop a panel of 
applications in diagnosis and medical therapy.  
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Figure captions 
Scheme 1. Reaction scheme of PVDF-g-PAA-TEG-peptide synthesis 
Figure 1. FTIR/ATR spectra of electron irradiated PVDF and PVDF-g-PAA. 
Figure 2. FTIR/ATR spectra of PVDF-g-PAA film before (
….
) and after (
___
) TEG binding. 
Figure 3. FTIR/ATR spectra of (…) PVDF-g-PAA-spacer-COO-NHS (4) and (__) PVDF-g-
PAA-TEG-peptide (5). 
Figure 4. 2D HR MAS 500 MHz 
1
H-
13
C HSQC spectrum of PVDF-g-PAA film swollen in 
DMF-d7 (grafting yield of 123 w %). 
Figure 5. HR MAS 500 MHz spectrum of PVDF-g-PAA-TEG-P(236-245) swollen in DMF-
d7.  
Figure 6. C1S core level X-ray photoelectron spectra: (Δ) raw data; 
….
 Base line; 
__
 fit; 
decomposition: PVDF ( ) CH2, (■) CF2 ; (□) C=O oxidation ; (○) CH2 PAA / C aliphatic + 
aromatic P(236-245); (▼) CH  PAA; (●) COO PAA/ester TEG/acid P(236-245) ; (▲) C-N 
amide/amine P(236-245); (◊) CO ether /alcohol; (◘) NH-C=O amide; (–•–) shake-up P(236-
245). 
Figure 7. ELISA test on pristine PVDF, irradiated PVDF, PVDF-g-PAA (1), PVDF-g-PAA-
TEG (2), BSA 3% and two PVDF-g-PAA-TEG-peptides (5) containing an antigen P(242-
261) and the control P(237-245).  
 
Table caption 
Table 1. Atomic percentage of C, O, F and N from XPS for each step of the surface 
functionalization ; PAA grafting yield is of 10 %. 
Samples C1S (%) F1S (%)* O1S (%) N1S (%) 
PVDF 49.3 47.5 3.2 0 
PVDF-g-PAA (1) 61.4 0.4 37.7 0 
PVDF-g-PAA-TEG (2) 73.3 0.2 22.9 3.6 
PVDF-g-PAA-TEG-P(236-245) (5) 69.3 0.7 22.0 8.0  
* <1%  base line error  
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